CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell TherapiesJesse Green, Terry J. Fry, Hanane Ennajdaoui et al.|Blood|2022Cited by 5
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell TherapyVandana Chaturvedi, Terry J. Fry, Jesse Green et al.|Blood|2023Cited by 3
Abstract LB311: Increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cellsJesse Green, Terry J. Fry, Brian Granger et al.|Cancer Research|2023Cited by 0
Relieving Restriction in Resting CD8+ T Cells Increases Gene Transfer and Improves Tumor Killing after Transduction with CD8-Targeted CD19CAR FusosomeMariliis Ott, Terry J. Fry, Hadega Aamer et al.|Blood|2024Cited by 0